March 28, 2025 - 22:48

US stock futures slipped as Wall Street continues to grapple with President Trump's escalating trade war. The financial markets are experiencing significant volatility, with major indices such as the Dow Jones Industrial Average dropping by 700 points. This sharp decline reflects growing concerns over tariffs and inflation, which are causing uncertainty among investors.
The S&P 500 and Nasdaq also faced steep losses, contributing to a broader sense of unease in the market. Analysts point to the potential repercussions of the ongoing trade disputes, which could lead to increased costs for consumers and businesses alike. The fear of rising inflation is further exacerbating the situation, as higher prices could diminish consumer spending and economic growth.
As traders respond to these developments, many are closely monitoring government policies and potential resolutions to the trade conflict. The current climate poses challenges for investors, who are navigating a landscape marked by unpredictability and heightened risk.
May 17, 2026 - 08:31
How Investors Are Reacting To NVE (NVEC) Steady Earnings And Maintained Quarterly DividendNVE Corporation has released its full-year results for the period ending March 31, 2026, posting revenue of US$26.33 million and net income of US$15.2 million. The company also confirmed a...
May 16, 2026 - 22:25
Risky Integration or Rewarding Returns? The Stakes of SoundHound's LivePerson Acquisition.SoundHound AI`s acquisition of LivePerson is drawing mixed reactions from investors, with the immediate fallout hitting the stock price. The deal, which combines SoundHound`s voice AI technology...
May 16, 2026 - 10:38
Bank of Hawaii, Glacier Bancorp, and Wintrust Financial Shares Plummet, What You Need To KnowShares of several regional banks took a sharp hit in afternoon trading Wednesday after the latest inflation report came in hotter than expected. The April Consumer Price Index rose 3.8%, a figure...
May 15, 2026 - 17:39
Plus Therapeutics Shares First Quarter 2026 Financial Results and Updates on REYOBIQ and CNSide ProgressHOUSTON, May 15, 2026 -- Plus Therapeutics, a healthcare company focused on precision diagnostics and radiopharmaceuticals for central nervous system cancers, reported its financial results for the...